➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Merck
Dow
Boehringer Ingelheim
Harvard Business School

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Sacubitril


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Sacubitril?

Sacubitril is an investigational drug.

There have been 72 clinical trials for Sacubitril. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2016.

The most common disease conditions in clinical trials are Heart Failure, Myocardial Infarction, and Hypertension. The leading clinical trial sponsors are Novartis Pharmaceuticals, RenJi Hospital, and The Cleveland Clinic.

There are one hundred and eighty-three US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Sacubitril
TitleSponsorPhase
Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019Novartis PharmaceuticalsPhase 1/Phase 2
Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019Duke UniversityPhase 1/Phase 2
The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial InfarctionWest China HospitalPhase 3

See all Sacubitril clinical trials

Clinical Trial Summary for Sacubitril

Top disease conditions for Sacubitril
Top clinical trial sponsors for Sacubitril

See all Sacubitril clinical trials

US Patents for Sacubitril

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sacubitril   Get Started Free ANP fragment adjuvant therapy to standard of care (SOC) diuretic treatment Madeleine Pharmaceuticals Pty Ltd. (Mount Barker, AU)   Get Started Free
Sacubitril   Get Started Free Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   Get Started Free
Sacubitril   Get Started Free Organic compounds INTRA-CELLULAR THERAPIES, INC. (New York, NY)   Get Started Free
Sacubitril   Get Started Free Synthetic linear apelin mimetics for the treatment of heart failure NOVARTIS AG (Basel, CH)   Get Started Free
Sacubitril   Get Started Free 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyr- imidin-4-ones as inhibitors of myeloperoxidase AstraZeneca AB (Sodertalje, SE)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sacubitril

Drugname Country Document Number Estimated Expiration Related US Patent
Sacubitril Australia AU2015230666 2034-04-09   Get Started Free
Sacubitril Australia AU2015230778 2034-04-09   Get Started Free
Sacubitril European Patent Office EP2968458 2033-03-15   Get Started Free
Sacubitril European Patent Office EP3116528 2033-03-15   Get Started Free
Sacubitril World Intellectual Property Organization (WIPO) WO2014138796 2033-03-15   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Merck
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.